Furosemide
Lasix, Frusemide
Also known as: Aldactone, Carospir
Potassium-SPARING. Raises serum potassium rather than lowering it, so the risk here is HYPERkalaemia, not hypokalaemia — and hyperkalaemia has its own conduction consequences. Frequently prescribed at dermatology doses for acne in young women, where neither patient nor clinician thinks of it as a cardiac drug.
Severity
Moderate caution
Mechanism
Electrolyte disturbance
Protocol Status
Continue as prescribed — cleared by a measured lab value, not a waiting period
Restart Delay
Physician discretion
What "Moderate caution" Means
Use with caution. Often requires a brief hold, dose reduction, or enhanced monitoring rather than full discontinuation.
Clinical Action
Measure K+ before dosing and read it for a HIGH value as well as a low one. Do NOT give empiric potassium to a patient on spironolactone. Magnesium should still be measured and corrected.
Where the Washout Happens
Continue as prescribed — cleared by a measured lab value, not a waiting period
This medication is not stopped for treatment, and should not be stopped on our initiative — the condition it treats usually outranks the interaction. What it changes is monitoring: serum potassium and magnesium are measured before the flood dose and corrected to target, and the dose is deferred until those numbers are right rather than until a number of days have passed. Any change to the prescription belongs to the prescribing physician.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
QTc is exquisitely sensitive to potassium and magnesium. Diuretics, laxatives, and conditions that lower these electrolytes lengthen QT and add to ibogaine's hERG effect. Pre-treatment electrolyte panels and IV repletion are routine.
Same Mechanism
Same Severity Tier
QT-interval prolongation
Zofran
QT-interval prolongation
Zithromax, Z-Pack
Cardiac conduction (bradycardia / AV node)
Lopressor, Toprol
Cardiac conduction (bradycardia / AV node)
Tenormin
Cardiac conduction (bradycardia / AV node)
Inderal
Cardiac conduction (bradycardia / AV node)
Coreg
Common Questions
Moderate caution. Potassium-SPARING. Raises serum potassium rather than lowering it, so the risk here is HYPERkalaemia, not hypokalaemia — and hyperkalaemia has its own conduction consequences. Frequently prescribed at dermatology doses for acne in young women, where neither patient nor clinician thinks of it as a cardiac drug. Measure K+ before dosing and read it for a HIGH value as well as a low one. Do NOT give empiric potassium to a patient on spironolactone. Magnesium should still be measured and corrected.
Continue as prescribed — cleared by a measured lab value, not a waiting period. This medication is not stopped for treatment, and should not be stopped on our initiative — the condition it treats usually outranks the interaction. What it changes is monitoring: serum potassium and magnesium are measured before the flood dose and corrected to target, and the dose is deferred until those numbers are right rather than until a number of days have passed. Any change to the prescription belongs to the prescribing physician.
Electrolyte disturbance. QTc is exquisitely sensitive to potassium and magnesium. Diuretics, laxatives, and conditions that lower these electrolytes lengthen QT and add to ibogaine's hERG effect. Pre-treatment electrolyte panels and IV repletion are routine.
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Spironolactone — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 145 medications in the A–Z directory.